M van Rooijen

14 papers receiving 410 citations

Peers

M van Rooijen
Comparison fields: 5 of 58
  • Molecular Biology 340
  • Genetics 128
  • Public Health, Environmental and Occupational Health 90
  • Surgery 78
  • Oncology 39
Replace Koen Theunis with:
Koen Theunis Belgium
Rolf‐Dieter Wegner Germany
Zhenyu Gu China
Nataline B. Kardon United States
Renée Bernstein South Africa
M.-F. de Tand France
Teresa Vendrell Spain
Nehal Gosalia United States
Xiang-Xu Jia China
Yuka Namiki Japan
M van Rooijen relative to Koen Theunis Belgium Koen Theunis's profile →
Citations per field
00.5×3.1×
Koen Theunis · 1×
Citations per year

Countries citing papers authored by M van Rooijen

Since Specialization
Citations

This map shows the geographic impact of M van Rooijen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M van Rooijen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M van Rooijen more than expected).

Fields of papers citing papers by M van Rooijen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M van Rooijen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M van Rooijen. The network helps show where M van Rooijen may publish in the future.

Co-authorship network of co-authors of M van Rooijen

This figure shows the co-authorship network connecting the top 25 collaborators of M van Rooijen. A scholar is included among the top collaborators of M van Rooijen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M van Rooijen. M van Rooijen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
#WorkIndexed citations
1 0
2 9
3 2
4 1
5 1
6 1
7
Prevalence, incidence and determinants of HCV infections among HIV-positive MSM attending a STI clinic, 1995-2010
1
8 2
9 48
10 27
11 44
12 161
13 49
14 59
15
Production of transforming growth factors by simian sarcoma virus-transformed cells.
13

About M van Rooijen

M van Rooijen is a scholar working on Microbiology, Hepatology and Epidemiology, having authored 15 papers that have together received 418 indexed citations. Recurring topics across this work include Renal and related cancers (3 papers), HIV, Drug Use, Sexual Risk (3 papers) and TGF-β signaling in diseases (2 papers). The work is most often cited by research in Molecular Biology (340 citations), Genetics (128 citations) and Public Health, Environmental and Occupational Health (90 citations). M van Rooijen has collaborated with scholars based in Netherlands, Italy and Ethiopia. Frequent co-authors include Christine L. Mummery, Marie‐José Goumans, Bernard A.J. Roelen, Michiel J. T. van Eijk, S. Modina, Alan Trounson, Simon Fisher, Harris A. Lewin, Helena T. A. van Tol and Gert E. Folkers. Their work appears in journals such as Proceedings of the National Academy of Sciences, Biology of Reproduction and Resources Conservation and Recycling.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026